Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S, German PTLD Study Group, European PTLD Network

Open source

DOI: 10.1016/s1470-2045(11)70300-x
Published: 2012 Feb
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-11-70300-x,
  title = {Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.},
  author = {Trappe R and Oertel S and Leblond V and Mollee P and Sender M and Reinke P and Neuhaus R and Lehmkuhl H and Horst HA and Salles G and Morschhauser F and Jaccard A and Lamy T and Leithäuser M and Zimmermann H and Anagnostopoulos I and Raphael M and Riess H and Choquet S and German PTLD Study Group and European PTLD Network},
  year = {2012},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(11)70300-x},
  url = {https://doi.org/10.1016/s1470-2045(11)70300-x}
}

RIS

TY  - JOUR
TI  - Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
AU  - Trappe R
AU  - Oertel S
AU  - Leblond V
AU  - Mollee P
AU  - Sender M
AU  - Reinke P
AU  - Neuhaus R
AU  - Lehmkuhl H
AU  - Horst HA
AU  - Salles G
AU  - Morschhauser F
AU  - Jaccard A
AU  - Lamy T
AU  - Leithäuser M
AU  - Zimmermann H
AU  - Anagnostopoulos I
AU  - Raphael M
AU  - Riess H
AU  - Choquet S
AU  - German PTLD Study Group
AU  - European PTLD Network
PY  - 2012
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(11)70300-x
UR  - https://doi.org/10.1016/s1470-2045(11)70300-x
ER  -

APA

R, T., S, O., V, L., P, M., M, S., P, R., R, N., H, L., HA, H., G, S., F, M., A, J., T, L., M, L., H, Z., I, A., M, R., H, R., S, C., Group, G. P. S., & Network, E. P. (2012). Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(11)70300-x

Source records

pubmed · retrieved 2026-09-26T02:01:01.258Z